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Background: Individuals with cystic fibrosis (CF) and pancreatic insufficiency (PI) are at risk for fat-soluble vitamin deficiency, including
vitamin A. Recent evidence suggests current practices of vitamin A intake results in elevated serum retinol.
Methods: Serum retinol was assessed in 78 subjects (8 to 25 years old) with CF and PI by high performance liquid chromatography, and
compared to the U.S. National Health and Nutrition Examination Survey (NHANES) data of subjects of similar age and gender. Vitamin A
intake, anthropometry and FEV1 were measured, and their relationship to serum retinol status was assessed.
Results: Median (range) serum retinol was 80 μg/dL (33 to 208) in subjects with CF; 58% were above the NHANES reference range (30 to
72 μg/dL). Total vitamin A intake from diet and supplements was high (608+431% Recommended Dietary Allowance). Serum retinol was
not correlated with vitamin A intake, age or gender, and was inversely correlated with weight and height z scores (r=−0.28, pb0.05) in the
subjects with CF.
Conclusions: Both vitamin A intake and serum retinol were elevated in subjects with CF and PI, corroborating recent evidence of elevated
serum retinol in preadolescent children with CF. These findings indicate the need for further study of dosing and monitoring care practices of
vitamin A, to ensure adequacy and to avoid toxicity.
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Cystic Fibrosis (CF) and pancreatic insufficiency (PI)
predisposes patients to fat and fat-soluble vitamin malab-
sorption, despite pancreatic enzyme replacement. Histori-
cally, individuals with CF have been prone to vitamin A
deficiency [1]. A recent study reported unexpectedly high
serum retinol concentrations and raised the question of
excessive supplementation. Current patterns of vitamin A
intake and supplementation may increase the risk for vitamin
A toxicity [2]. The goal of this study was to document the
vitamin A status and to verify or refute these unexpected
findings with a broader age range cohort of children anded by Elsevier B.V. All rights reserved.
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age- and sex-matched reference data from the U.S. National
Health and Nutrition Examination Survey (NHANES) [3].
2. Materials and methods
Children and young adults (8 to 25 years old) with CF and
PI were recruited from a pediatric and adult CF Center.
Inclusion criteria included diagnosis of CF and PI by
standard methods [2]. Subjects with FEV1b40% predicted
and those with other major medical illnesses that affect
growth were excluded.
Serum retinol (ug/dL) was collected by research person-
nel at The Children's Hospital of Philadelphia Clinical
Translational Research Center and analyzed by high
performance liquid chromatography (HPLC) (Clinical Nu-
trition Research Unit Nutrition Assessment Laboratory,
University of California, Davis) under research protocols
with quality assurance measures. Serum retinol levels of
subjects with CF were compared with NHANES 1999–2002
[3] serum reference ranges (5th to 95th percentiles) from age-
equivalent white subjects (88% of which were non-hispanic
whites), using HPLC (Division of Environmental Health
Services, Centers for Disease Control and Prevention,
Atlanta, GA) and with similar research protocol and quality
assurance measures.
Height and weight were measured using standard tech-
niques [4], with a stadiometer accurate to 0.1 cm (Holtain,
Crymych, UK) and a digital scale accurate to 0.1 kg
(Scaletronix, White Plains, NY). All measurements were
obtained in triplicate and the mean used in the analyses. Z
scores for height (HAZ), weight (WAZ), and body mass
index (BMI; kg/m2, BMIZ) were computed [5]. Pulmonary
function was evaluated by standard methods for spirometry
[6,7]. FEV1 percent predicted was calculated using the Wang
et al [8] and Hankinson et al [9] equations.
Research dieticians determined dietary intake from 3-day
weighed food records. Vitamin A intake, as food- and
supplement-based, pre-formed and total retinol, were reported
in retinol activity equivalents per day (μg RAE/d). The
vitamin A intake of subjects with CF was compared with
Dietary Reference Intake (DRI) [10] Recommended DietaryTable 1
Clinical characteristics of the 78 subjects with cystic fibrosis and pancreatic
insufficiency
Characteristic Mean±SD (range)
Age, years 14.5±4.0 (8.4, 25.2)
Gender, % male 48
Weight for age Z-score −0.54±1.06 (−3.67, 2.15)
Height for age Z-score −0.59±0.98 (−2.63, 1.99)
BMI for age Z-score −0.26±0.90 (−2.73, 1.97)
FEV1, % predicted 86±15 (47, 118)
Serum Retinol, μg/dL 82±29 (33, 208)
Median, μg/dL1 80
1Median value (range) presented given due to non-normality.Allowance (RDA) and Tolerable Upper Intake Levels (UL)
which are age and gender based, and with the CF Foundation
Recommendations, which are age-based [11,12].
All variables were tested for normality and skewness.
Group comparisons were tested using Student's t-test or
Wilcoxon rank sum test for normally or non-normally
distributed variables, respectively. Data were presented as
mean±standard deviation; median values and range were
used for the serum retinol due to non-normality. Pearson
correlation coefficients or Spearman rank correlations were
performed to test for significant associations between
variables as appropriate. Statistical significance was defined
as a P-valueb0.05. All analyses were performed with STATA
release 8.2 (STATA Corporation, College Station, TX).
The protocol was approved by the Committee for the
Protection of Human Subjects of the Institutional Review
Board at the Children's Hospital of Philadelphia and the
Hospital of the University of Pennsylvania. Informed written
consent was obtained from each subject 18 years and older. For
subjects between 8 and 18 years of age, written consent was
obtained from each subject’s parent or legal guardian, and
written assent was obtained from every study subject under
18 years of age.
3. Results
Serum retinol, anthropometry and FEV1 were available for
78 subjects (Table 1). Seven subjects (9%) participated in both
the previously cited pre-adolescent study [2] and the current
study. Dietary intake data were available for 53 subjects. In
comparison to subjects with complete dietary data, the subjects
without dietary data had lower%FEV1 (81±13 versus 89±16;
p=0.04). Forty-two percent of subjects had serum retinol
within and 58% had concentrations above the NHANES
reference range of 30 to 72 μg/dL (Fig. 1); none of the subjects
with CF and PI had a serum retinol below the lower reference
range value of 30 μg/dL.
Total vitamin A intake (mean± sd) from food and
supplement (Table 2) was 608±431% RDA, with 67%
from supplements. Total preformed retinol intake was 564±
409 % RDA, with 86% of subjects exceeding the UL [10]
Table 2
Energy and Vitamin A intake for the subjects with cystic fibrosis and
pancreatic insufficiency (n=53)
Dietary intake Mean±SD Median Range
Energy intake, kcal/d 2786±827 2616 1617 to 5293
Vitamin A intake
Food
Preformed retinol
μg RAE/d 1107±1410 852 120 to 10,499
μg RAE/kg/d 26±25 21 3 to 172
%RDA1 167±204 132 17 to 1500
Total Vitamin A
μg RAE/d 1279±1510 1012 150 to 11,330
%RDA 216±252 169 25 to 1888
Supplemental
Preformed retinol
μg RAE/d 2580±1905 2700 0 to 9188
μg RAE/kg/d 61±56 54 0 to 350
%RDA 397±362 333 0 to 2297
Total Vitamin A
μg RAE/d 2692±1908 2700 0 to 9188
%RDA 415±364 375 0 to 2297
Combined food and supplement
Preformed retinol
μg RAE/day 3687±2223 3332 437 to 12,479
μg RAE/kg/d 87±61 78 9 to 386
%RDA 564±409 485 73 to 2538
% CF Recommendations2 123+74 111 15 to 416
Total Vitamin A
μg RAE/day 3972±2359 3614 503 to 13,850
%RDA 608±431 521 84 to 2631
% CF Recommendations 132±79 120 17 to 462
1 Recommended dietary intake is age and gender based, and ranges from 400
to 900 μg RAE/day (10). 2CF recommendations are age-based, and for
children 4 to 8 years of age are from 5000 to10,000 IU/day, and for children
and adults greater than 8 years of age are 10,000 IU day±1500 to 3000 RAE/
day) (11,12). The conversion of IU to RAE is: 1 IU retinol=0.3 μg RAE.
1 μg RAE=1 ug retinol.
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Recommendations [11].
For the subject sample with dietary data, serum retinol
was inversely correlated with HAZ and WAZ (−0.28,
Pb0.04; −0.28, Pb0.05), and not associated with FEV1,
age, gender, or vitamin A intake (food, supplement-based,
and/or total). When the study subjects were divided into
groups as within or above the NHANES serum retinol
reference ranges, there were no group differences in
anthropometry, %FEV1, and food and supplement-based
(pre-formed or total) vitamin A intake.
4. Discussion
These results showed that under current patterns of care,
58% of subjects with CF and PI had elevated serum retinol
concentrations using NHANES reference data for compar-
ison. None of these subjects were vitamin A deficient based
on serum retinol status.
Elevated serum retinol was previously documented in a
group of pre-adolescent children with CF and PI [2] from astudy involving 13 US CF Centers. Mean serum retinol was
52±13 μg/dL (range: 26 to 98), significantly higher than the
age-similar NHANES reference group mean of 37±10 μg/
dL. In the pre-adolescent group, 47% of subjects had serum
retinol concentrations N95th percentile, compared with 58%
in the current study. Our present study corroborates these
findings in a broader age range, raising further concerns
about elevated serum retinol concentrations, high vitamin A
intake, and the risk for vitamin A toxicity in the CF
population.
The term “vitamin A” refers to a family of compounds
important for cellular integrity, growth, and immune
function, that is comprised of preformed retinoids and pro-
vitamin A carotenoids. Retinoids are fat-soluble, animal-
derived compounds that include retinol, retinal, and retinoic
acids. Ingested retinoids are solubilized and esterified into
retinyl esters (RE) in the intestine, circulated as both bound
RE and unbound retinol, and stored in the liver as retinol.
While the serum retinol concentration is homeostatically
maintained, hepatic stores accumulate indefinitely with
increased ingestion. Conversely, pro-vitamin A carotenoids
are water-soluble, plant-derived compounds that include
carotene, lutein, and xanthophylls. They are less bio-
available than retinoids and amounts ingested in excess of
needs are not stored but are excreted.
The amount of vitamin A contained in a given food or
supplement is described using either international units (IU) or
microgram retinol activity equivalents (μg RAE). The former
is an outdated unit that does not account for discrepant
bioavailability and bioactivity of the different forms of
vitamin A. The RAE is the current standard unit which
incorporates these differences and allows direct comparison
among all different forms of vitamin A. Conversion
equations:one μgRAE=1 μg retinol=12 μg β-carotene
from food=24 μg other provitamin A carotenoids. One IU
retinol=0.3 μg RAE=3.6 μg β-carotene from fruits and
vegetables=7.2 μg other pro-vitamin A carotenoids [13].
In addition to the form of vitamin A, the specific
preparation of vitamin A supplement is relevant when
considering the potential for toxicity [10]. Some vitamin A
formulas used in the CF population are now biochemically
engineered to increase the water-solubility of retinoids, to
allow for easier absorption in the setting of pancreatic
insufficiency. These preparations are helpful when there is
ongoing malabsorption, but may also confer more risk for
the development of elevated serum retinol and potential
vitamin A toxicity in this population. A meta-analysis of
259 case reports of chronic hypervitaminosis A in children
and adults without CF suggested relatively smaller doses
(200 μg RAE/kg/day) of water-miscible, emulsified, and
solid forms of retinol supplements ingested over shorter
time intervals (weeks to months) induced similar toxicity as
oil-based preparations given in larger doses (2,000 μg RAE/
kg/day) over months to years [14]. Water-miscible pre-
formed vitamin A supplements were used by 58% of our
subjects.
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specific vitamin A supplement-based intake recommenda-
tions; children between four and eight years of age were
recommended to take between 5000 and 10,000 IU/day, and
children greater than eight years of age and adults were to
take 10,000 IU/day. Further, both the pediatric and adult
consensus reports [11,12] recommend monitoring of vitamin
A status by serum retinol concentration determination at the
time of diagnosis, and annually afterwards.
The commonly used CF-specific vitamin products
contain water-miscible vitamin A, between 897 to 2520 μg
RAE per dosage unit, with 40 to 100% as preformed retinol
[2]. Preformed vitamin A is more bioavailable, more readily
stored, and not subject to the same feedback control as
provitamin A carotenoids. Therefore, knowledge of each
specific vitamin A formulation is important to the proper
evaluation and monitoring of vitamin A supplementation. In
the current study, many individuals with CF took many
different vitamin supplement products, and some used more
than one type of vitamin A supplement per day. In the current
study, 27 different vitamin A supplement products were
used, and 11% of subjects used more than one type of
vitamin A supplement per day; one subject used three
different vitamin A-containing supplements per day.
Vitamin A toxicity primarily affects the bone and liver.
The bone fracture rate was increased by 64% among non-CF
Swedish men with serum retinol above 76 μg/dL compared
to those with concentrations between 62 and 67 μg/dL [15].
Mean serum retinol in the current study was similar to this
higher fracture risk group. Vitamin A intake and bone
toxicity has been reported with preformed vitamin A intakes
as low as 1500 ug RAE/day in non-CF subjects [16].
Preformed retinol intake between 1500 to N14,000 ug RAE/
day over one to 30 years was associated with a spectrum of
liver abnormalities [10,17]. Pre-existing/coincident liver
disease may alter the threshold for vitamin A associated
toxicity [10,18]. This is an important clinical concern for
patients with CF, since CF associated liver disease is usually
diagnosed in children and adolescents [19].
Hepatic vitamin A status of subjects with CF has been
investigated in a limited number of studies in the past. The
liver is the main storage site for vitamin A, and vitamin A
status has previously been described in subjects with CF,
examining both serum and hepatic vitamin A status. A 1972
study [20] reported significantly higher hepatic and lower
serum retinol concentrations in 12 vitamin A supplemented
subjects with CF (8 to 23 years old) compared to healthy
controls. Another study found normal hepatic retinol
concentrations in 15 vitamin A supplemented Swedish
subjects with CF (8 to 34 years old) compared to healthy
controls [19]; hepatic retinyl palmitate decreased with age,
serum retinol was 36±17 μg/dL (range 2 to 57 μg/dL), and
33% of subjects had values less than 30 μg/dL. In contrast
to this study, we found normal and high serum retinol
levels in subjects of comparable age range, and no subjects
with low levels. Similar to the Swedish study [19] how-ever, we did not find an association between serum retinol
and age.
The limitations of this study included its cross-sectional
design, and the fact that the vitamin A analysis was secondary
within the bone health in people with cystic fibrosis study.
Currently there is no well-accepted, non-invasive marker for
the assessment of vitamin A excess. Serum retinol is tightly
regulated, decreases with depleted hepatic stores [21], and is
likely a better bio-marker of vitamin A deficiency rather than
excess. Serum retinol increases with long-term supplement
use, and intake of foods high in preformed vitamin A. Serum
retinol elevations may reflect increased hepatic stores;
however, the threshold value to indicate elevated hepatic
stores is not known. Retinyl esters have been noted to be
elevated with excess vitamin A intake or increased liver stores
[22]; these were not available in the current study. Retinol
binding protein usually parallels the serum retinol level; both
of these biomarkers of vitamin A status can be depressed in
the setting of inflammation, and thus is not an optimal
indicator of vitamin A status in diseases such as CF, with a
chronic inflammation component. This is particularly
concerning when serum retinol is elevated in these subjects
with CF, as it may underestimate degree of vitamin A excess.
In summary, these findings raise concern about current
vitamin A supplementation practices and products. Children
and young adults had similar findings of high vitamin A
intake and elevated serum retinol concentrations as com-
pared to pre-adolescent children with CF and PI. Routine use
of preformed, water-miscible vitamin A supplements may
result in elevated serum retinol concentrations and may
increase the risk for hypervitaminosis A in this population. It
is unknown if CF-related liver or bone disease alters the risk
for hypervitaminosis A. Serum retinol should be routinely
monitored at least on an annual basis, as recommended by
the 2002 and 2004 Pediatric and Adult Consensus Reports
on Nutrition for Patients with CF [11,12]. We suggest
adjusting the dose accordingly to the results in order to
maintain normal serum retinol. Further studies of vitamin A
status are warranted, including determination of serum
retinyl esters, and possibly even liver biopsy to determine
hepatic vitamin A stores. Furthermore, the development of
non-invasive methods to measure hepatic and total body
stores of vitamin A would enhance the ability to monitor
vitamin A supplementation. A better understanding of the
relationship between serum and tissue vitamin A is needed
for patients with CF. In the meanwhile clinicians should be
aware of the composition of different vitamin A supplement
preparations and dosing equivalents taken by their patients.
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